Related Experiment Video
Updated: Nov 4, 2025
10:44
Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
10.0K
Substrate Selectivity of Coumarin Derivatives by Human CYP1 Enzymes: In Vitro Enzyme Kinetics and In Silico Modeling
Risto O Juvonen1, Mira Ahinko2, Elmeri M Jokinen3
1School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Box 1627, 70211 Kuopio, Finland.
ACS Omega
|May 31, 2021
Summary
Researchers developed new coumarin substrates to selectively measure activity of human cytochrome P450 family 1 enzymes (CYP1A1, CYP1A2, CYP1B1). Compounds 14, 19, and 20 show promise in replacing less specific traditional substrates for drug metabolism studies.
Area of Science:
- Biochemistry and Molecular Biology
- Pharmacology and Drug Metabolism
- Enzyme Kinetics and Analysis
Background:
- Human cytochrome P450 family 1 (CYP1) enzymes, including CYP1A2, CYP1A1, and CYP1B1, play crucial roles in metabolizing xenobiotics and drugs.
- Existing CYP1 substrates like 7-ethoxycoumarin lack selectivity, being oxidized by all CYP1 forms, hindering specific enzyme activity assessment.
- There is a need for selective substrates to accurately measure the activity of individual CYP1 enzymes, particularly CYP1A2 in the liver and CYP1A1/CYP1B1 in extrahepatic tissues.
Purpose of the Study:
- To synthesize and identify novel profluorescent coumarin derivatives as selective substrates for individual human CYP1 enzymes.
- To evaluate the substrate selectivity and efficiency of synthesized coumarin derivatives for CYP1A1, CYP1A2, and CYP1B1.
- To elucidate the molecular interactions within the active sites of CYP1 enzymes that govern substrate selectivity using computational methods.
Main Methods:
- Synthesis of eleven 3-phenylcoumarin derivatives.
- Determination of enzyme kinetic parameters (e.g., catalytic efficiency) for coumarin derivatives using purified CYP1 enzymes.
- In silico analysis including molecular docking and dynamic simulations to understand enzyme-substrate interactions in the active sites.
Main Results:
- All synthesized coumarin derivatives were oxidized by at least one CYP1 enzyme.
- Compound 19 showed broad specificity, efficiently demethylated by all CYP1 forms.
- Compound 14 selectively demethylated by CYP1A1 with low efficiency, attributed to favorable active site interactions.
- Compound 20 demonstrated highest efficiency with CYP1B1, followed by CYP1A1 and CYP1A2, linked to complex stability variations.
Conclusions:
- Compounds 14, 19, and 20 are identified as potential selective substrates for human CYP1 enzymes.
- These novel coumarin derivatives can potentially replace traditional, less selective substrates in assays measuring CYP1 enzyme activity.
- The study provides insights into structure-activity relationships and molecular interactions governing CYP1 enzyme selectivity.
More Related Videos
Related Concept Videos
01:16Protein-Drug Binding: Mechanism and Kinetics
1.3K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.3K
01:26Pharmacokinetic Models: Comparison and Selection Criterion
187
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
187
01:16Methods for Studying Drug Absorption: In vitro
420
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
420
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
125
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
125
01:20Determination of Michaelis Constant and Maximum Elimination Rate
220
The Michaelis constant (KM) and the theoretical maximum process rate (Vmax) are vital parameters in the Michaelis-Menten equation, central to many biochemical reactions. They provide essential insights into enzyme kinetics and drug metabolism.
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
220
01:19Enzyme Kinetics
101.4K
Enzymes speed up reactions by lowering the activation energy of the reactants. The speed at which the enzyme turns reactants into products is called the rate of reaction. Several factors impact the rate of reaction, including the number of available reactants. Enzyme kinetics is the study of how an enzyme changes the rate of a reaction.
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
101.4K